Stock Analysis | Agilent Technologies Outlook - A Weak Technical Picture and Mixed Analyst Sentiment

Market Snapshot

Headline Takeaway: Agilent Technologies is showing a weak technical outlook with an internal diagnostic score of 1.75, suggesting caution in the near term.

News Highlights

Recent developments in the broader market and specific industry news include:

• Walmart's AI Strategy: Walmart is embracing agentic AI to transform the retail landscape, which could influence supply chain and customer interaction dynamics in the sector. This shift might indirectly impact Agilent's business in diagnostics or related fields.
• Modine Acquires Heating Solutions: Modine's $112 million acquisition of L.B. White's heating business highlights ongoing consolidation in the industrial and specialty manufacturing space, potentially affecting Agilent in terms of competition or market dynamics.
• Agilent's Sector: While not directly mentioned in the news, Agilent’s performance could be influenced by broader healthcare and diagnostics trends, such as changes in U.S. vaccination policies or new medical technology developments.

Analyst Views & Fundamentals

Analysts have delivered a mixed picture of Agilent Technologies. The simple average rating is 3.50, while the performance-weighted rating stands at 3.21. The ratings are relatively consistent, with no major dispersion among the four institutions covering the stock (Wells Fargo, Evercore ISI Group, Baird, and Barclays).

This aligns loosely with the current price trend, which has seen a 6.36% rise in the last five days. However, the technical analysis indicates a weak outlook, suggesting that this upward movement may be fragile.

Key fundamental metrics include:

• EBIT / Total operating revenue: 19.56%, with an internal diagnostic score of 9.92, signaling strong operating profitability.
• CFOA (Cash flow from operating activities): $0.0182 million, with an internal diagnostic score of 9.92, indicating robust operational cash generation.
• Gross Profit Margin (GPM): 51.92%, with an internal diagnostic score of 9.92, showing healthy margins.
• Cash-UP: -0.65, with an internal diagnostic score of 9.92, indicating potential liquidity strength.
• Equity Multiplier: 199.47%, with an internal diagnostic score of 9.92, showing high leverage in the DuPont analysis framework.

These fundamentals suggest a company with strong operating cash flow and good margins, although the leverage is high and should be carefully watched.

Money-Flow Trends

Money-flow patterns for Agilent Technologies show a negative overall trend, with the following inflow ratios:

• Small investors: 49.75% inflow ratio
• Medium investors: 48.34% inflow ratio
• Large investors: 45.46% inflow ratio
• Extra-large investors: 50.37% inflow ratio

Despite the mixed sentiment from analysts, big-money flows are showing caution, particularly among institutional investors, with the extra-large inflow ratio being the only positive. Retail activity is relatively high, but overall, the money flow score of 7.85 (classified as "good") contrasts with the technical analysis, which shows weakness.

Key Technical Signals

The technical outlook is bearish, with only 0 bullish indicators and 2 bearish ones. Key indicators include:

• Williams %R Overbought: This indicator has a score of 2.04, suggesting a moderate bias toward caution. It has historically shown a win rate of 43.18% and an average return of 14.00%.
• Earnings Release Date: With a score of 1.47, this is the most bearish signal and historically has had a win rate of just 33.33% and an average return of 13.00%.

Recent technical signals include multiple appearances of the Williams %R Overbought indicator on 20250822, 20250828, and 20250820. The Earnings Release Date was also noted on 20250827, indicating that recent chart patterns are bearish and suggest a lack of momentum.

Key Insight: The technical side is weak, and it is suggested to avoid the stock due to the dominance of bearish signals (2 bearish vs 0 bullish) and the lack of strong positive momentum.

Conclusion

Agilent Technologies is currently showing a weak technical outlook with an internal diagnostic score of 1.75. Despite strong fundamentals and some positive analyst ratings, the bearish technical signals and negative money flows suggest caution. Given the recent Earnings Release Date and the recurring Williams %R Overbought indicator, it may be prudent to watch upcoming earnings closely and consider waiting for a clearer positive trend before making a move.